Calamos Advisors LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 5 filers reported holding IMMUNOMEDICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$10,398,000
+58.5%
2,500,0000.0%0.05%
+41.7%
Q3 2019$6,560,000
-4.8%
2,500,0000.0%0.04%
-5.3%
Q2 2019$6,888,000
-27.7%
2,500,0000.0%0.04%
-35.6%
Q1 2019$9,530,000
+33.2%
2,500,0000.0%0.06%
+25.5%
Q4 2018$7,154,000
-30.8%
2,500,0000.0%0.05%
-17.5%
Q3 2018$10,338,000
-12.0%
2,500,0000.0%0.06%
-20.8%
Q2 2018$11,743,000
+60.3%
2,500,0000.0%0.07%
+50.0%
Q1 2018$7,324,000
-9.5%
2,500,0000.0%0.05%
+17.1%
Q4 2017$8,096,000
+14.6%
2,500,0000.0%0.04%
-25.5%
Q3 2017$7,065,0002,500,0000.06%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Graham Capital Management, L.P. 17,594,000$51,944,0001.39%
WOLVERINE ASSET MANAGEMENT LLC 3,950,000$11,618,0000.15%
Jefferies Group LLC 3,889,000$11,591,0000.06%
Calamos Advisors LLC 2,500,000$7,324,0000.05%
AMERIPRISE FINANCIAL INC 1,000,000$2,950,0000.00%
View complete list of IMMUNOMEDICS INC shareholders